Vifor Pharma AG (LTS:0RPD) EV-to-FCF : 33.61 (As of Apr. 28, 2024)

Vifor Pharma AG EV-to-FCF Chart

Vifor Pharma AG Annual Data
	Trend	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21
EV-to-FCF		Get a 7-Day Free Trial					-271.60	-101.26	26.54	242.38	33.92

Vifor Pharma AG Semi-Annual Data
	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
EV-to-FCF	Get a 7-Day Free Trial															26.54	-	242.38	-	33.92

Competitive Comparison of Vifor Pharma AG's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Vifor Pharma AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vifor Pharma AG's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vifor Pharma AG's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Vifor Pharma AG's EV-to-FCF falls into.

Vifor Pharma AG EV-to-FCF Calculation

Vifor Pharma AG's EV-to-FCF for today is calculated as:

Vifor Pharma AG's current Enterprise Value is CHF10,375 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vifor Pharma AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2021 was CHF309 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vifor Pharma AG  (LTS:0RPD) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Vifor Pharma AG's PE Ratio (TTM) for today is calculated as:

Vifor Pharma AG's share price for today is CHF165.55.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vifor Pharma AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2021 was CHF2.220.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Vifor Pharma AG EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Vifor Pharma AG's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Vifor Pharma AG (LTS:0RPD) Business Description